HIGH-FREQUENCY OF MEMORY AND EFFECTOR GAG SPECIFIC CYTOTOXIC LYMPHOCYTES-T IN HIV SEROPOSITIVE INDIVIDUALS

被引:120
作者
GOTCH, FM [1 ]
NIXON, DF [1 ]
ALP, N [1 ]
MCMICHAEL, AJ [1 ]
BORYSIEWICZ, LK [1 ]
机构
[1] ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 2QQ,ENGLAND
基金
英国惠康基金;
关键词
Cytotoxic T lymphocyte; HIV; Peptide (epitopes); Precursor frequency;
D O I
10.1093/intimm/2.8.707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) specific cytotoxic T lymphocytes (CTL) have been detected in most patients following infection. It has also been suggested that the specific CTL response, which may play an important role in delaying disease in infected humans, may decline during the course of disease progression. We have measured HIV peptide specific CTL precursor frequency by limiting dilution analysis in two healthy seropositive patients whose fresh peripheral blood mononuclear cells (PBM) specifically lysed MHC matched target cells (restricted by HLA B27 and B8 respectively). The frequency of HIV peptide specific CTL precursors is high (3 x 10-3-10-4), but lower than estimates of circulating CTL with the same specific cytotoxic activity present directly in peripheral blood using the same sample (10-2/10-3). We suggest that this difference may result from terminal effector CTL differentiation in the T cell lineage. This implies that only a subset of CTL effectors have growth potential, whereas relatively higher levels of CTL with lytic activity can be detected in PBM of healthy HIV seropositive patients. © 1990 Oxford University Press.
引用
收藏
页码:707 / 712
页数:6
相关论文
共 18 条
[1]  
AUTRAN B, 1988, AIDS, V2137, P174
[2]   HUMAN CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS - THEIR PRECURSOR FREQUENCY AND STAGE SPECIFICITY [J].
BORYSIEWICZ, LK ;
GRAHAM, S ;
HICKLING, JK ;
MASON, PD ;
SISSONS, JGP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (02) :269-275
[3]   T-IMMUNOGENIC PEPTIDES ARE CONSTITUTED OF RARE SEQUENCE PATTERNS - USE IN THE IDENTIFICATION OF T-EPITOPES IN THE HUMAN IMMUNODEFICIENCY VIRUS GAG PROTEIN [J].
CLAVERIE, JM ;
KOURILSKY, P ;
LANGLADEDEMOYEN, P ;
CHALUFOURPROCHNICKA, A ;
DADAGLIO, G ;
TEKAIA, F ;
PLATA, F ;
BOUGUELERET, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1547-1553
[4]  
HOFFENBACH A, 1989, J IMMUNOL, V142, P452
[5]  
KOUP RA, 1989, BLOOD, V73, P1909
[7]   CTL - VIRUS CONTROL-CELLS 1ST AND CYTOLYTIC CELLS 2ND - DNA FRAGMENTATION, APOPTOSIS AND THE PRELYTIC HALT HYPOTHESIS [J].
MARTZ, E ;
HOWELL, DM .
IMMUNOLOGY TODAY, 1989, 10 (03) :79-86
[8]   T-CELL STRATEGIES IN AIDS VACCINES - MHC-RESTRICTED T-CELL RESPONSES TO HIV PROTEINS [J].
MILLS, KHG ;
NIXON, DF ;
MCMICHAEL, AJ .
AIDS, 1989, 3 :S101-S110
[9]   HIV-1 GAG-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T DEFINED WITH RECOMBINANT VACCINIA VIRUS AND SYNTHETIC PEPTIDES [J].
NIXON, DF ;
TOWNSEND, ARM ;
ELVIN, JG ;
RIZZA, CR ;
GALLWEY, J ;
MCMICHAEL, AJ .
NATURE, 1988, 336 (6198) :484-487
[10]  
NORUSIS M, 1988, SPSS PC PLUS V2 0